Tenor Capital Management Co., L.P. Esperion Therapeutics, Inc. Transaction History

Tenor Capital Management Co., L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.46 - $7.3 $206,912 - $1.03 Million	141,721 Added 885.15%	157,732 $250,000
Q4 2022 Feb 14, 2023	SELL	$5.09 - $8.5 $864,419 - $1.44 Million	-169,827 Reduced 91.38%	16,011 $99,000
Q4 2021 Feb 14, 2022	BUY	$4.81 - $11.92 $893,880 - $2.22 Million	185,838 New	185,838 $929,000

211

129M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $124M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Tenor Capital Management Co., L.P., based on Form 13F filings with the SEC.

Stay updated on Tenor Capital Management Co., L.P. with notifications on news.